医薬品適正使用:処方医薬品の副作用検索システムの開発

スポンサーリンク

概要

著者

関連論文

Alterations of Binding Characteristics of α_1-, β_1-Adrenoceptors and Ca^ Binding Sites in the Myocardium of Spontaneously Hypertensive Rats (SHR) by Chronically Administered Bunazosin, Atenolol, Ketanserin and Verapamil
Binding Characteristics of [^3H] Dihydroalprenolol to β-Adrenergic Receptors of Rat Brain : Comparison with Those of Rat Heart Treated with Neuraminidase
医薬品適正使用のための患者イベントの点数化の試み: loxoprofen sodiumを事例として
医薬品適正使用:処方箋からの患者の医療情報検索システムの開発
Effects of Ketanserin and 3-[2-[4-(o-Methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H, 3H)-quinazolinedione Monohydrochloride (SGB-1534), Anti-hypertensive Agents, on ^3H-Serotonin and ^3H^Ketanserin Bindings to Serotonergic (5HT_1 and 5HT_2) Receptors in Dog B
Effect of 3-[2-[4-(o-Methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H, 3H)-quinazolinedione Monohydrochloride (SGB-1534), an Anthihypertensive Agent, on ^3H-Prazosin and ^3H-p-Aminoclonidine Binding to α_1-and α_2-Adrenoceptors in Dog Brain and Arta
Effects of Choline and Inositol on ^3H-Dihydroalprenolol and ^I-Iodocyanopindolol Bindings to β-Adrenegic Receptors of the Guinea Pig Cerebral Cortical Membranes
Characterization of ^3H-Dihydroalprenolol Binding to β-Adrenergic Receptors of Rat Brain : Two Binding Sites of Racemic Propranolol in Displacement Experiments(Pharmacological)
Biphasic Binding of ^I-Iodocyanopindolol to β-Adrenergic Receptors in Rat Cerebral Cortical Membranes. I. Assessment by the Use of Agonists(Pharmacological)
Adrenergic and Serotonergic Receptor-Blocking Potencies of Terazosin, a New Antihypertensive Agent, as Assessed by Radioligand Binding Assay(Pharmacological)
医薬品の情報提供
ホームページ利用による学生への教育用情報の公開
医薬品適正使用:処方医薬品の副作用検索システムの開発

もっと見る

スポンサーリンク